Cleopatra Hospital CoCAI:CLHO -2.69%88 PEG Ratio is 1.15 as of Jul. 02, 2026, which is 21% above its 10-year median of 0.95. GuruFocus rates CAI:CLHO with a GF Score™ of 88/100 and a GF Value™ of E£13.90 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 225 Healthcare Providers & Services companies, Cleopatra Hospital Co ranks better than 59.56% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Cleopatra Hospital Co's PEG Ratio or its related term are showing as below:
CAI:CLHO'
s PEG Ratio Range Over the Past 10 Years
Min: 0.48 Med: 0.95 Max: 4.6
Current: 1.15
During the past 11 years, Cleopatra Hospital Co's highest PEG Ratio was 4.60. The lowest was 0.48. And the median was 0.95.
CAI:CLHO's PEG Ratio is ranked better than 59.56% of 225
companies
in the Healthcare Providers & Services industry
Industry Median: 1.39
vs CAI:CLHO: 1.15
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Cleopatra Hospital Co (CAI:CLHO) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cleopatra Hospital Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cleopatra Hospital Co PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Cleopatra Hospital Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Cleopatra Hospital Co (CAI:CLHO) has a PEG Ratio of 1.15 as of Jul. 02, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Cleopatra Hospital Co and its competitors. This is 21% above median its historical median of 0.95. Over the past decade, Cleopatra Hospital Co's PEG Ratio has ranged from 0.48 to 4.60. According to the industry distribution chart, Cleopatra Hospital Co ranks #91 out of 225 companies in the Healthcare Providers & Services industry, placing it in the top 40.4%.
Is Cleopatra Hospital Co's PEG Ratio too high?
Cleopatra Hospital Co's current PEG Ratio of 1.15 is 21% above median its 10-year median of 0.95. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 4.60. The Healthcare Providers & Services industry median PEG Ratio is 1.39. Cleopatra Hospital Co's value of 1.15 is 17.3% below this industry median. Based on the distribution chart, Cleopatra Hospital Co ranks #91 out of 225 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cleopatra Hospital Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's PEG Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cleopatra Hospital Co ranks #91 out of 225 companies for PEG Ratio. This puts Cleopatra Hospital Co in the upper half of its industry. The industry median PEG Ratio is 1.39. Cleopatra Hospital Co's value of 1.15 is 17.3% below this benchmark. Historically, Cleopatra Hospital Co's own PEG Ratio has ranged from 0.48 to 4.60 over the past decade. While the company's 10-year median is 0.95 vs. the industry median of 1.39, Cleopatra Hospital Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.39, based on 225 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cleopatra Hospital Co's current PEG Ratio of 1.15 is 17.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Cleopatra Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cleopatra Hospital Co's current PEG Ratio is 1.15, which is 21% above median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£13.90, compared to a current price of E£16.30 — trading 17.3% above its estimated fair value. The current PEG Ratio is 1.15, which is 21% above median its 10-year median of 0.95 and 17.3% below the Healthcare Providers & Services industry median of 1.39. Cleopatra Hospital Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current PEG Ratio is 1.15 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?
Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued.
The current stock price of E£16.30 is trading 17.3% above its estimated GF Value™ of E£13.90.
GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.
Key valuation signals for CAI:CLHO:
PEG Ratio: 1.15 (21% above median its 10-year median of 0.95)
GF Value™: E£13.90 vs. price of E£16.30 (17.3% above fair value)
Industry Position: 17.3% below the Healthcare Providers & Services median (#91 of 225)
No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
88GF Score
Get the complete analysis for CAI:CLHO
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:CLHO has been successfully added to your 
